Ads
related to: sentinel x100 vs f1 inhibitor 50 lbs for sale in stock list
Search results
Results from the WOW.Com Content Network
The stock continues to trade at a wide discount to peers on a price-to-sale (P/S) basis, despite similar revenue growth to CrowdStrike (29% last quarter) and much higher revenue growth than Palo ...
From a valuation perspective, SentinelOne is the much cheaper stock, trading at less than half the forward price-to-sales (P/S) multiple of CrowdStrike based on next year's estimates (7.5x vs 19 ...
CrowdStrike's tech blunder might open the door for SentinelOne to benefit.
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and SentinelOne wasn’t one of them. The 10 stocks that made the ...
SentinelOne stock could be a buy if the company can just keep growing.
SentinelOne, Inc. is an American cybersecurity company listed on NYSE based in Mountain View, California. [2] [3] [4] The company was founded in 2013 by Tomer Weingarten, Almog Cohen and Ehud ("Udi") Shamir.
For premium support please call: 800-290-4726 more ways to reach us
Defactinib (INN, codenamed VS-6063) is an inhibitor of PTK2, also known as focal adhesion kinase (FAK), Pyk2, and MELK which was developed by Pfizer and licensed to Verastem Oncology as a potential treatment for solid tumors. Development for mesothelioma was discontinued in 2015 due to lack of efficacy in a placebo-controlled phase II trial.
Ads
related to: sentinel x100 vs f1 inhibitor 50 lbs for sale in stock list